View Author
scopus: 35378025000

Rood, J.J. van

( J.J. van Rood)


class donor mismatch ctlp assay transplantation assay mhc class i patient t-cell marrow survival outcome frequency difference ctlp frequencies graft ctlp assay outcome t-cell alloreactivity bone marrow transplantation analysis group transplant blood antigen hazard cell transplantation alloreactivity x 5a category x 5a mismatch ratio sequence hazard ratio depletion sct outcome parameter allogeneic table study recipient molecule amino-acid multivariate analysis category mortality ligand signi cytotoxic heemskerk hla-c ficant response 106 pbl number t-cell depletion ctlp frequency multivariate patient survival histocompatibility killer immunol selection signi ficant hematopoietic disease van rood jj effect vivo t-cell depletion mismatch ctlp neg allogeneic ctl response 4 years cell donors europdonor foundation histocompatibility antigens leukaemia method diagnosis hla-a leiden –recipient speci




1 Most Recent Publications

Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation (Article)
Heemskerk, M.B.A. Cornelissen, J.J. Roelen, D.L. Rood, J.J. van Claas, F.H.J. Doxiadis, I.I.N. Oudshoorn, M.
2007-08-01